UBS Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-399,284
| Closed | -$18.6M | – | 8983 |
|
|
2023
Q2 | $18.6M | Buy |
399,284
+383,140
| +2,373% | +$17.8M | 0.01% | 1094 |
|
|
2023
Q1 | $463K | Buy |
16,144
+7,058
| +78% | +$202K | ﹤0.01% | 3766 |
|
|
2022
Q4 | $283K | Buy |
9,086
+8,963
| +7,287% | +$280K | ﹤0.01% | 4119 |
|
|
2022
Q3 | $2K | Buy |
+123
| New | +$2K | ﹤0.01% | 8741 |
|
|
2022
Q2 | – | Sell |
-2,059
| Closed | -$39K | – | 10095 |
|
|
2022
Q1 | $39K | Sell |
2,059
-2,372
| -54% | -$44.9K | ﹤0.01% | 5720 |
|
|
2021
Q4 | $112K | Buy |
+4,431
| New | +$112K | ﹤0.01% | 5152 |
|